British Society for Antimicrobial Chemotherapy

British Society for Antimicrobial Chemotherapy

Abbreviation	BSAC
Formation	1971
Founded at	Birmingham, United Kingdom
Purpose	Working to address the growing threat of antimicrobial resistance around the world.

The British Society for Antimicrobial Chemotherapy (BSAC) is a UK-based multi-professional organisation committed to addressing the growing threat of drug resistant infections – one of the one of the top global public health and development threats .

As one of the world’s largest networks of infection specialists, BSAC has thousands of members and works with a wide range of stakeholders, including researchers, scientists, health care providers, policymakers, and industry leaders to support their work and help them reach a global audience.

On receiving BSAC's highest award, the Garrod Medal, in 2021, Dame Sally Davies, the UK's Special Envoy on Antimicrobial Resistance, commented: "For fifty years, BSAC have been at the forefront of the global fight against AMR...enabling communities globally to be more than the sum of their parts."

Activities

Current BSAC activities include:

• Publishes the Journal of Antimicrobial Chemotherapy and its sister publication, JAC-AMR.
• Provides accreditation to hospitals as part of its Global Antimicrobial Stewardship Scheme (GAMSAS), a programme of work that was used as a case study in the Government of the United Kingdom's National Action Plan on antimicrobial resistance, ‘Confronting antimicrobial resistance 2024 to 2029’.
• Out-patient parenteral antibiotic therapy (OPAT) Initiative. The OPAT Initiative is involved in the development of a body of evidence that include good practice recommendations, a business case toolkit and a patient management system to support clinicians in the provision of parenteral antibiotics away from the hospital in-patient setting.

External links

• British Society for Antimicrobial Chemotherapy website